Australia Patent: Regeneron Pharmaceuticals Files Application for 'Methods of treating allergy using anti-Bet v 1 antibodies'

  • Meagan P. O'Brien

Press/Media

Period9 Dec 2022

Media coverage

1

Media coverage

  • TitleAustralia Patent: Regeneron Pharmaceuticals Files Application for 'Methods of treating allergy using anti-Bet v 1 antibodies'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date9/12/22
    PersonsMeagan P. O'Brien
View all 1
View less